secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0000950170-24-123322
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight Q3 revenue $35.3M (+59% YoY); raises FY revenue guidance to $139-140M
-----------------------------------------------------------------------------

- Revenue $35.3M, up 59% YoY; LAL procedures 24,554 (+80%), LDD installed base 888 (+51%).
- Gross margin 71.4% vs 61.9% YoY; net loss narrowed to $6.3M ($0.16/sh) from $12.4M ($0.35/sh).
- Adjusted net earnings $214K ($0.00/diluted) vs adjusted loss $6.9M ($0.19/sh) a year ago.
- FY2024 revenue guidance raised to $139-140M top of prior range; gross margin guided 70-71% (up from 68-70%).
- Cash & equivalents $237.1M at Sept 30, 2024 vs $233.3M at June 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017024123322/0000950170-24-123322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017024123322/rxst-20241107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-123322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer